PlasmaFlo® is a proprietary blend of proteolytic and fibrinolytic enzymes, concentrated plant extracts and potent antioxidants. Formulated to support the integrity of capillaries and improve the flowing properties of blood, PlasmaFlo® helps the delivery of vital nutrients, oxygen and stem cells throughout the entire body for optimum health.*
PlasmaFlo® supports 3 vital vascular components:
1. Vascular flow – PlasmaFlo® provides enzyme nutrition to support the digestion of fibrin mesh in the bloodstream to improve circulation in capillaries.*
2. Vascular integrity – PlasmaFlo® contains plant extracts that effectively support the integrity of capillary health.*
3. Vascular health – PlasmaFlo® contains antioxidants to provide optimum nutrition to help prevent the formation of fibrin and combat oxidative stress and vascular inflammation.*
What does PlasmaFlo® do?
Formulated to support the integrity of capillaries and improve the flowing properties of blood, PlasmaFlo® helps the delivery of vital nutrients, oxygen and stem cells throughout the entire body for optimum health.*
How does PlasmaFlo® support health?
Supports the integrity of blood vessels and capillaries* Supports healthy blood flow* Helps assist the body with reducing oxidative stress in the blood* Helps support the circulation of stem cells*
Can PlasmaFlo® be consumed with other Cerule® products and other nutrients?
Yes, the Cerule products can be consumed together and were designed to enhance the beneficial effects of each other. We know of no known concerning interaction between the Cerule products and other nutritional supplements. For a full list of PlasmaFlo® Q&As, go to Cerule Back Office or ask the IBO that provided this Product Fact Page for assistance.
To obtain the optimum benefit from the enzymes it is recommended to take 2 capsules daily 30 minutes before or 2 hours after a meal. For adult consumption.
No dairy, wheat, gluten, peanut, soy or corn allergens No artificial flavors or colors 100% vegetarian and vegetable capsules Non-GMO Pregnancy and nursing are considered special conditions. We recommend that your attending doctor(s) be made aware of any and all supplements consumed during this time. At this time, we do not advise PlasmaFlo® consumption during pregnancy. If you have any health condition and/or are using any medication then consult your attending health care provider before consuming any nutritional supplement.
For further information go to:
NATURAL CONCENTRATES & EXTRACTS
Górnaś P, Šnē E, Siger A, Segliņa D. Sea buckthorn (Hippophae rhamnoides L.) vegetative parts as an unconventional source of lipophilic antioxidants. Saudi J Biol Sci. 2016 Jul;23(4):512-6. Kruczek M1, Swiderski A, Mech-Nowak A, Król K. Antioxidant capacity of crude extracts containing carotenoids from the berries of various cultivars of Sea buckthorn (Hippophae rhamnoides L.). Acta Biochim Pol. 2012;59(1):135-7. Epub 2012 Mar 17.
Corti R, Flammer AJ, Hollenberg NK, Lüscher TF. Cocoa and cardiovascular health. Circulation. 2009 Mar 17;119(10):1433-41. Mastroiacovo D, Kwik-Uribe C, Grassi D, Necozione S, Raffaele A, Pistacchio L, Righetti R, Bocale R, Lechiara MC, Marini C, Ferri C, Desideri G. Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study–a randomized controlled trial. Am J Clin Nutr. 2015 Mar;101(3):538- 48.
Umeno A, Horie M, Murotomi K, Nakajima Y, Yoshida Y. Antioxidative and Antidiabetic Effects of Natural Polyphenols and Isoflavones. Molecules. 2016 May 30;21(6). Tejada S, Pinya S, Del Mar Bibiloni M, Tur JA, Pons A, Sureda A. Cardioprotective effects of the polyphenol hydroxytyrosol from olive oil. Curr Drug Targets. 2016 Oct 5.
De Sanctis MT, Belcaro G, Incandela L, Cesarone MR, Griffin M, Ippolito E, Cacchio M. Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebocontrolled, randomized, dose-ranging trial. Angiology. 2001 Oct;52 Suppl 2:S55-9.
Mix JA, Crews WD Jr. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol. 2002 Aug;17(6):267-77.
Park JW, Kwon HJ, Chung WS, Kim CY, Seong GJ. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma. Korean J Ophthalmol. 2011 Oct;25(5):323-8.
Mastantuono T, Battiloro L, Sabatino L, Chiurazzi M, Di Maro M, Muscariello E, Colantuoni A, Lapi D. Effects of Citrus Flavonoids Against Microvascular Damage Induced by Hypoperfusion and Reperfusion in Rat Pial Circulation. Microcirculation. 2015 Jul;22(5):378-90.
Struckmann JR. Clinical efficacy of micronized purified flavonoid fraction: an overview. J Vasc Res. 1999;36 Suppl 1:37-41. Review. Kishimoto Y, Yoshida H, Kondo K. Potential Anti-Atherosclerotic Properties of Astaxanthin. Mar Drugs. 2016 Feb 5;14(2). pii: E35. Baralic I, Andjelkovic M, Djordjevic B, Dikic N, Radivojevic N, Suzin-Zivkovic V, Radojevic-Skodric S, Pejic S. Effect of Astaxanthin Supplementation on Salivary IgA, Oxidative Stress, and Inflammation in Young Soccer Players. Evid Based Complement Alternat Med. 2015;2015:783761.
Régnier P, Bastias J, Rodriguez-Ruiz V, Caballero-Casero N, Caballo C, Sicilia D, Fuentes A, Maire M, Crepin M, Letourneur D, Gueguen V, Rubio S, Pavon-Djavid G. Astaxanthin from Haematococcus pluvialis Prevents Oxidative Stress on Human Endothelial Cells without Toxicity. Mar Drugs. 2015 May 7;13(5):2857-74.
Kotb E. The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi. Biotechnol Prog. 2014 May-Jun;30(3):656-72. Sumi H, Hamada H, Nakanishi K, Hiratani H. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol. 1990;84(3):139-43.
Numan D, Da Silva MA, Wikner LK, Duckert F. Thrombolytic treatment of arterial occlusions with brinase, a proteolytic enzyme produced by aspergillus. Schweiz Med Wochenschr. 1974 Dec 14;104(50):1865-7.